Bartlett & Co. Wealth Management LLC Novo Nordisk A S Transaction History

Bartlett & Co. Wealth Management LLC

$7.34 Billion
Q3 2025

A detailed history of Bartlett & Co. Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 41,016 shares of NVO stock, worth $1.99 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

41,016

Previous 42,920 4.44%

Holding current value

$1.99 Million

Previous $2.96 Billion 99.92%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 09, 2025	SELL	$45.38 - $71.7 $86,403 - $136,516	-1,904 Reduced 4.44%	41,016 $2.28 Million
Q2 2025 Jul 18, 2025	BUY	$58.08 - $81.05 $1,974 - $2,755	34 Added 0.08%	42,920 $2.96 Billion
Q1 2025 Apr 24, 2025	SELL	$69.3 - $90.95 $2 Million - $2.62 Million	-28,859 Reduced 40.22%	42,886 $3.03 Billion
Q3 2024 Oct 17, 2024	SELL	$119.07 - $145.42 $264,335 - $322,832	-2,220 Reduced 3.0%	71,745 $8.54 Billion
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $3.05 Million - $4.07 Million	-29,916 Reduced 28.8%	73,965 $9.57 Billion

Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $53,282 - $64,008	607 Added 0.59%	103,881 $10.7 Billion
Q3 2023 Feb 14, 2024	BUY	$90.94 - $199.54 $4.7 Million - $10.3 Million	51,637 Added 100.0%	103,274 $9.39 Billion
Q4 2022 Feb 14, 2024	SELL	$102.55 - $135.33 $159,670 - $210,708	-1,557 Reduced 2.93%	51,637 $6.99 Billion
Q1 2022 Feb 14, 2024	SELL	$93.1 - $112.54 $116,840 - $141,237	-1,255 Reduced 2.3%	53,194 $5.96 Billion
Q3 2021 Feb 13, 2024	SELL	$84.42 - $106.62 $2,026 - $2,558	-24 Reduced 0.04%	54,449 $5.23 Billion
Q1 2021 Feb 13, 2024	SELL	$67.06 - $75.82 $90,531 - $102,356	-1,350 Reduced 2.42%	54,473 $3.68 Billion
Q4 2020 Feb 13, 2024	SELL	$63.89 - $73.8 $55,200 - $63,763	-864 Reduced 1.52%	55,823 $3.9 Billion
Q3 2020 Feb 13, 2024	SELL	$63.69 - $70.22 $47,767 - $52,665	-750 Reduced 1.31%	56,687 $3.94 Billion
Q1 2020 Feb 13, 2024	SELL	$49.46 - $64.78 $135,025 - $176,849	-2,730 Reduced 4.54%	57,437 $3.5 Billion
Q4 2019 Feb 13, 2024	SELL	$49.86 - $58.26 $17,949 - $20,973	-360 Reduced 0.59%	60,167 $3.48 Billion
Q3 2019 Feb 13, 2024	BUY	$47.54 - $53.43 $31,709 - $35,637	667 Added 1.11%	60,527 $3.13 Billion
Q2 2019 Feb 13, 2024	SELL	$46.79 - $52.47 $18,248 - $20,463	-390 Reduced 0.65%	59,860 $3.06 Billion
Q1 2019 Feb 13, 2024	SELL	$46.36 - $52.63 $92,720 - $105,260	-2,000 Reduced 3.21%	60,250 $3.2 Billion
Q4 2018 Feb 13, 2024	SELL	$41.54 - $47.25 $3,738 - $4,252	-90 Reduced 0.14%	62,250 $2.87 Billion
Q2 2018 Feb 13, 2024	SELL	$44.29 - $50.42 $17,937 - $20,420	-405 Reduced 0.65%	62,340 $2.88 Billion
Q1 2018 Feb 13, 2024	BUY	$48.49 - $58.14 $3.04 Million - $3.65 Million	62,745 New	62,745 $3.14 Billion

Others Institutions Holding NVO

# of Institutions

1,697

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.

Account

Bartlett & Co. Wealth Management LLC Novo Nordisk A S Transaction History